Created at Source Raw Value Validated value
June 25, 2024, noon usa

inclusion criteria: 1. participant is willing to give written informed consent for participation in the trial. 2. participants should receive 2 doses of the azd1222. evidence of this will be gathered from medical history and/or medical records including the covid-19 vaccine registration yellow card.

inclusion criteria: 1. participant is willing to give written informed consent for participation in the trial. 2. participants should receive 2 doses of the azd1222. evidence of this will be gathered from medical history and/or medical records including the covid-19 vaccine registration yellow card.

Nov. 25, 2021, 9 p.m. usa

inclusion criteria: participant is willing to give written informed consent for participation in the trial. participants should receive 2 doses of the azd1222. evidence of this will be gathered from medical history and/or medical records including the covid-19 vaccine registration yellow card.

inclusion criteria: participant is willing to give written informed consent for participation in the trial. participants should receive 2 doses of the azd1222. evidence of this will be gathered from medical history and/or medical records including the covid-19 vaccine registration yellow card.